Clovis Oncology, Inc. Debt Conversion, Converted Instrument, Amount
Clovis Oncology, Inc. reported Debt Conversion, Converted Instrument, Amount of $35.85 million for the 56-month period ending 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2014-02-28
- Clovis Oncology, Inc. debt conversion, converted instrument, amount for fiscal 2011 was $35.85M.
| Period end | Debt Conversion, Converted Instrument, Amount 12 month | Debt Conversion, Converted Instrument, Amount 44 month | Debt Conversion, Converted Instrument, Amount 47 month | Debt Conversion, Converted Instrument, Amount 50 month | Debt Conversion, Converted Instrument, Amount 53 month | Debt Conversion, Converted Instrument, Amount 56 month |
|---|---|---|---|---|---|---|
| 2013-12-31 | $35.85M 10-K · filed 2014-02-28 | |||||
| 2013-09-30 | $35.85M 10-Q · filed 2013-11-07 | |||||
| 2013-06-30 | $35.85M 10-Q · filed 2013-08-07 | |||||
| 2013-03-31 | $35.85M 10-Q · filed 2013-05-08 | |||||
| 2012-12-31 | $35.85M 10-K · filed 2013-03-14 | |||||
| 2011-12-31 | $35.85M 10-K · filed 2014-02-28 |